Design of the COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint study (CONFIDENCE)

PaperCitations, authors & open-access status

Design of the COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint study (CONFIDENCE) is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 162 citations, 2022 year and hybrid oa status.